Your browser doesn't support javascript.
loading
Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management.
Pathmanathan, Shivanshan; Tariq, Arsalan; Pearce, Adam; Rhee, Handoo; Kyle, Samuel; Raveenthiran, Sheliyan; Wong, David; McBean, Rhiannon; Marsh, Phillip; Goodman, Steven; Dhiantravan, Nattakorn; Esler, Rachel; Dunglison, Nigel; Navaratnam, Anojan; Yaxley, John; Thomas, Paul; Pattison, David A; Goh, Jeffrey C; Gan, Chun Loo; Roberts, Matthew J.
Afiliación
  • Pathmanathan S; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Tariq A; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.
  • Pearce A; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Rhee H; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.
  • Kyle S; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Raveenthiran S; Wesley Urology Clinic, The Wesley Hospital, Brisbane, Queensland, Australia.
  • Wong D; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • McBean R; Department of Urology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Marsh P; Department of, Medical Imaging, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Goodman S; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Dhiantravan N; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.
  • Esler R; Department of Urology, Redcliffe Hospital, Brisbane, Queensland, Australia.
  • Dunglison N; I-MED Radiology, The Wesley Hospital, Brisbane, Queensland, Australia.
  • Navaratnam A; I-MED Radiology, The Wesley Hospital, Brisbane, Queensland, Australia.
  • Yaxley J; Department of Diagnostic Radiology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Thomas P; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Pattison DA; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Goh JC; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.
  • Gan CL; Wesley Urology Clinic, The Wesley Hospital, Brisbane, Queensland, Australia.
  • Roberts MJ; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.
Eur J Nucl Med Mol Imaging ; 51(1): 295-303, 2023 12.
Article en En | MEDLINE | ID: mdl-37592084
PURPOSE: There is an emerging role of the use of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in renal cell carcinoma. Herein, we report our experience in use of PSMA PET in recurrent or metastatic renal cell carcinoma (RCC). METHODS: A retrospective analysis of all patients who underwent PSMA PET for suspected recurrent or de-novo metastatic RCC between 2015 and 2020 at three institutions was performed. The primary outcome was change in management (intensification or de-intensification) following PSMA PET scan. Secondary outcomes included histopathological correlation of PSMA avid sites, comparison of sites of disease on PSMA PET to diagnostic CT and time to systemic treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Carcinoma de Células Renales / Neoplasias Renales Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Carcinoma de Células Renales / Neoplasias Renales Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2023 Tipo del documento: Article